Goodpasture syndrome epidemiology and demographics: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million person a year, with high prevalence in Caucasians. The peak incidence of the disease occurs between the ages of 20 and 30 and again at 60 and 70. <ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million person a year, with high prevalence in Caucasians. The peak incidence of the disease occurs between the ages of 20 and 30 and again at 60 and 70. <ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | ||
== Epidemiology == | |||
===Age=== | ===Age=== | ||
The age at which Goodpasture syndrome occurs in two peaks 1) ages 20 and 30 2) ages 60 and 70.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | The age at which Goodpasture syndrome occurs in two peaks 1) ages 20 and 30 2) ages 60 and 70.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | ||
Revision as of 17:33, 4 November 2016
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Goodpasture syndrome epidemiology and demographics |
|
Goodpasture syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Goodpasture syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million person a year, with high prevalence in Caucasians. The peak incidence of the disease occurs between the ages of 20 and 30 and again at 60 and 70. [1]
Epidemiology
Age
The age at which Goodpasture syndrome occurs in two peaks 1) ages 20 and 30 2) ages 60 and 70.[1]
Gender
Males are at higher risk of developing Goodpasture syndrome at a younger age while females are at higher risk later in life.[1]
Race
In European populations between half and one case presents per million people per year. It is rarer than this in non-European populations.
References
- ↑ 1.0 1.1 1.2 Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.